Philippines

12 Vaccines Approved for Use in Philippines

Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 6 countries
7 trials in 3 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: bloomberg.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: bloomberg.com
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
16 trials in 2 countries
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: bloomberg.com
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Approval Source: fda.gov.ph
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com

16 in Clinical Trials in Philippines

Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
Protein Subunit

Livzon Mabpharm Inc

V-01

Approved in 1 country
7 trials in 3 countries
Protein Subunit

SK Bioscience Co Ltd

GBP510

6 trials in 6 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

9 trials in 5 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Replicating Viral Vector

Wantai

DelNS1-2019-nCoV-RBD-OPT1

5 trials in 3 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Protein Subunit

Jiangsu Rec-Biotechnology Co Ltd

ReCOV

6 trials in 3 countries
Protein Subunit

SK Bioscience Co Ltd

SKYCovione

Approved in 1 country
7 trials in 6 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Inactivated

KM Biologics Co Ltd

KD-414

7 trials in 2 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
RNA

GlaxoSmithKline

CV0501

Protein Subunit

EuBiologics Co Ltd

EuCorVac-19

4 trials in 3 countries